scispace - formally typeset
A

Anastasia S. Mihailidou

Researcher at Royal North Shore Hospital

Publications -  75
Citations -  7710

Anastasia S. Mihailidou is an academic researcher from Royal North Shore Hospital. The author has contributed to research in topics: Aldosterone & Blood pressure. The author has an hindex of 26, co-authored 64 publications receiving 6929 citations. Previous affiliations of Anastasia S. Mihailidou include Kolling Institute of Medical Research & Macquarie University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial.

TL;DR: Important health outcomes were similar after 1 month of optimal MAD and CPAP treatment in patients with moderate-severe OSA, although MAD was superior to CPAP for improving four general quality-of-life domains.
Journal ArticleDOI

Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction

TL;DR: Spironolactone acts not merely by excluding corticosteroids from mineralocorticoid receptors but as a protective inverse agonist at low concentration, which may provide an additional therapeutic advantage in unstable angina and acute myocardial infarction.
Journal ArticleDOI

Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement

TL;DR: Although clinic measurement of BP will continue to be useful for screening and management of suspected and true hypertension, ABP monitoring provides considerable added value toward accurate diagnosis and the provision of optimal care in uncomplicated hypertension, as well as for patients with moderate or severe CVD risk.